- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Government revokes anti-dumping duty imposed on Amoxicillin imports from China
New Delhi: Through a recent gazette notification, the Central Government has revoked the anti-dumping duty imposed on 'Amoxycillin' also known as 'Amoxycillin Trihydrate' originating in or exported from China PR and imported into India. The product falls under tariff item 2941 10 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975).
"In exercise of the powers conferred by sub-sections (1) and (5) of section 9A of the Customs Tariff Act, 1975 (51 of 1975), the Central Government revokes the anti-dumping duty imposed on 'Amoxycillin' also known as 'Amoxycillin Trihydrate', falling under tariff item 2941 10 30 of the First Schedule to the said Act, originating in or exported from China PR and imported into India and hereby rescinds the notification of the Government of India in the Ministry of Finance (Department of Revenue) No. 21/2017-Customs(ADD) dated the 16th May, 2017, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide number G.S.R. 476(E), dated 16th May, 2017, except as respect things done or omitted to be done before such rescission," the recent Gazette notification read.
Amoxicillin is an antibiotic used to treat a number of bacterial infections i.e., middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections. The antibiotic can be taken by mouth, or less commonly by injection.
In 2017 the government of India had levied definitive anti-dumping duty on import of Amoxycillin originating in or exported from China PR for a period of five years. This came in light to protect domestic production of the molecule as the government had reached the conclusion that
(i) the presence of dumped imports in the country is suppressing the prices of the domestic industry;
(ii) imports are undercutting the prices of the domestic industry and that the price undercutting has led to significant increase in market share of imports and decline in market share of the Indian industry;
(iii) material injury to the domestic industry has been caused by dumped imports.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751